Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of glycolytic pathways for inhibiting or measuring oncogenic signaling

Use of glycolytic pathways for inhibiting or measuring oncogenic signaling

US Patent 9689042 · Granted Jun 27, 2017

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Peptides, compositions, and methods for stimulating subcutaneous adipogenesis2020
Peptides that stimulate subcutaneous adipogenesis2020
Peptides that stimulate subcutaneous adipogenesis2019
Detecting and treating breast cancer resistance to EGFR inhibitors2016
Modulation of Rhamm (CD168) for selective adipose tissue development2014
Method of increasing radiation sensitivity by inhibition of beta one integrin2012
Drug screens based on the newly found role of dystroglycan proteolysis and resto2010
Method of increasing radiation sensitivity by inhibition of beta one integrin2009
Design of novel assays based on the newly found role of dystroglycan and alpha-d2006
Human AZU-1 gene, variants thereof and expressed gene products2004
Utilization of nuclear structural proteins for targeted therapy and detection of2001
Method for restoration of normal phenotype in cancer cells2000